India Health Ministry Addresses Industry Concerns About Drugs and Cosmetic Law
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - In an effort to address drug industry concerns related to inspection powers and other issues in the Drugs and Cosmetics (Amendment) Bill, India's Health Ministry says it plans to form a committee of experts to make recommendations on implementation